244 related articles for article (PubMed ID: 17253770)
21. Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
Carver JA; Duggan PJ; Ecroyd H; Liu Y; Meyer AG; Tranberg CE
Bioorg Med Chem; 2010 Jan; 18(1):222-8. PubMed ID: 19931462
[TBL] [Abstract][Full Text] [Related]
22. Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.
Lemkul JA; Bevan DR
Biochemistry; 2010 May; 49(18):3935-46. PubMed ID: 20369844
[TBL] [Abstract][Full Text] [Related]
23. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
24. The binding of resveratrol to monomer and fibril amyloid beta.
Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
[TBL] [Abstract][Full Text] [Related]
25. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro.
Naiki H; Gejyo F; Nakakuki K
Biochemistry; 1997 May; 36(20):6243-50. PubMed ID: 9166797
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.
Rivière C; Richard T; Quentin L; Krisa S; Mérillon JM; Monti JP
Bioorg Med Chem; 2007 Jan; 15(2):1160-7. PubMed ID: 17049256
[TBL] [Abstract][Full Text] [Related]
27. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates.
Söderberg L; Dahlqvist C; Kakuyama H; Thyberg J; Ito A; Winblad B; Näslund J; Tjernberg LO
FEBS J; 2005 May; 272(9):2231-6. PubMed ID: 15853808
[TBL] [Abstract][Full Text] [Related]
28. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
Yamin G; Ruchala P; Teplow DB
Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
30. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
Sakono M; Zako T; Ueda H; Yohda M; Maeda M
FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
[TBL] [Abstract][Full Text] [Related]
31. Influence of dendrimer's structure on its activity against amyloid fibril formation.
Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
[TBL] [Abstract][Full Text] [Related]
32. Mechanical unbinding of abeta peptides from amyloid fibrils.
Raman EP; Takeda T; Barsegov V; Klimov DK
J Mol Biol; 2007 Oct; 373(3):785-800. PubMed ID: 17868685
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the interaction between Abeta 1-42 and glyceraldehyde phosphodehydrogenase.
Verdier Y; Földi I; Sergeant N; Fülöp L; Penke Z; Janáky T; Szücs M; Penke B
J Pept Sci; 2008 Jun; 14(6):755-62. PubMed ID: 18219703
[TBL] [Abstract][Full Text] [Related]
34. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
Ouberai M; Dumy P; Chierici S; Garcia J
Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
[TBL] [Abstract][Full Text] [Related]
36. Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils.
Sato N; Okochi M; Taniyama Y; Kurinami H; Shimamura M; Takeuchi D; Hamada H; Fukumori A; Kiyosue K; Taguchi T; Tanaka T; Miyasaka M; Takeda M; Ogihara T; Morishita R
Neurobiol Dis; 2006 Jun; 22(3):487-95. PubMed ID: 16488151
[TBL] [Abstract][Full Text] [Related]
37. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.
Harper JD; Wong SS; Lieber CM; Lansbury PT
Biochemistry; 1999 Jul; 38(28):8972-80. PubMed ID: 10413470
[TBL] [Abstract][Full Text] [Related]
38. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
[TBL] [Abstract][Full Text] [Related]
39. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
40. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
